Datamatics forms strategic partnership with Bangalore International Airport
Datamatics forms strategic partnership with Bangalore International Airport

Datamatics forms strategic partnership with Bangalore International Airport

Apurva Joshi Article rating: 4.3

Bangalore International Airport Limited (BIAL) has formed strategic technology partnership with Datamatics Global Services Limited (DGSL) to transform BIAL into a future-ready digital organization. This involves automating and digitizing more than 170 processes across the organization.

Glenmark gains 2.3 per cent on reorganisation plans
Glenmark gains 2.3 per cent on reorganisation plans

Glenmark gains 2.3 per cent on reorganisation plans

DSIJ Intelligence Article rating: 3.5

Glenmark Pharmaceuticals announced that it has initiated the process of reorganising itself into three different entities. The shares of the company rose 2.3 per cent intraday post the announcement on Thursday.


Aditya Birla Capital to raise Rs. 2,100 crore
Aditya Birla Capital to raise Rs. 2,100 crore

Aditya Birla Capital to raise Rs. 2,100 crore

DSIJ Intelligence Article rating: 5.0

Aditya Birla Capital, one of the largest financial services players in India has received approval from the board of directors to raise Rs. 2,100 crore. Shares of ABCL gained over 2 per cent intraday.


MCX rallies on MoU with Zhengzhou Commodity Exchange
MCX rallies on MoU with Zhengzhou Commodity Exchange

MCX rallies on MoU with Zhengzhou Commodity Exchange

DSIJ Intelligence Article rating: 4.4

Multi Commodity Exchange of India Ltd. (MCX) has signed Memorandum of Understanding (MoU) with one of the leading commodity exchanges in China Zhengzhou Commodity Exchange (ZCE).


Dr. Reddy introduces Bupropion Hydrochloride ER tablets
Dr. Reddy introduces Bupropion Hydrochloride ER tablets

Dr. Reddy introduces Bupropion Hydrochloride ER tablets

Apurva Joshi Article rating: 4.3

Dr. Reddy’s Laboratories Limited has announced the launch of Bupropion Hydrochloride Extended-Release Tablets, USP (SR), a therapeutically equivalent generic version of Zyban (Bupropion Hydrochloride) Extended-Release Tablets, approved by the U.S. Food and Drug Administration (USFDA).

Cochin Shipyard wins order for building 23 boats
Cochin Shipyard wins order for building 23 boats

Cochin Shipyard wins order for building 23 boats

Amir Shaikh Article rating: 4.5

Cochin Shipyard, on Thursday, informed the bourses that it has bagged order for building 23 boats for the Kochi Water Metro Project from Kochi Metro Rail Limited (KMRL).

Tips to childproof your retirement
Tips to childproof your retirement

Tips to childproof your retirement

DSIJ Intelligence Article rating: 5.0

When it comes to retirement, most people think that their children will take care of all the things in retirement. But that does not happen always. So, you need to childproof your retirement. Let’s find out how can you to achieve it.

Ten stocks close to their 52-weeks high
Ten stocks close to their 52-weeks high

Ten stocks close to their 52-weeks high

DSIJ Intelligence Article rating: 3.5

The markets on September 05, 2019 opened gap down. BSE Sensex is trading at 36,601.03, down by 117.71 points and the Nifty is trading at 10,826.55, down by 18.10 points.

Power Grid surges on new order win
Power Grid surges on new order win

Power Grid surges on new order win

DSIJ Intelligence Article rating: 5.0

Power Grid Corporation of India Limited has been declared the successful bidder under tariff based competitive bidding to establish transmission system for intrastate transmission work of 400 kV and 220 kV in Madhya Pradesh.

RSS
First31303131313231333135313731383139Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR